Atossa Gains IP for Breast Cancer Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Atossa Genetics today announced it has acquired intellectual property from the Dr. Susan Love Research Foundation covering a biomarker test for breast cancer.

Atossa has acquired all ownership rights to US Patent No. 7,879,614 and pending US application 11/958,597. Both patents cover the manufacture, use, and sale of a biomarker test for the analysis of carbohydrates contained in nipple aspirate fluid using a sensitive detection reagent such as a Schiff's reagent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.